References
- Barac A, Kosmidis C, Alastruey-Izquierdo A, Salzer HJF. Chronic pulmonary aspergillosis update: A year in review. Medical Mycology. 2019;57(Supplement_2): S104–S109.
- Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management. European Respiratory Journal. 2016;47(1): 45–68.
- Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bulletin of the World Health Organization. 2011;89(12): 864–872.
- Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, et al. Treatment of chronic pulmonary aspergillosis: Current standards and future perspectives. Respiration. 2018;96(2): 159–170.
- The Lancet Respiratory Medicine. Chronic pulmonary aspergillosis: Help is on the way. The Lancet Respiratory Medicine. 2016;4(2): 83.
- Jaramillo J, Yadav R, Herrera R. Why every word counts: Towards patient- and people-centered tuberculosis care. International Journal of Tuberculosis and Lung Disease. 2019;23(5): 547–551.
- Redondo M, Keyt H, Dhar R, Chalmers JD. Global impact of bronchiectasis and cystic fibrosis. Breathe (Sheff). 2016;12(3): 222–235.
- McDonnell MJ, Jary HR, Perry A, MacFarlane JG, Hester KL, Small T, et al. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respiratory Medicine. 2015;109(6): 716–726.
- Maiz L, Giron R, Olveira C, Vendrell M, Nieto R, Martínez-García MA. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: A multicenter observational study. BMC Infectious Disease. 2016;16(1): 437.
- Maiz L, Vendrell M, Olveira C, Girón R, Nieto R, Martínez-García MÁ. Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis. Respiration. 2015;89(5): 396–403.
- Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Annals of the American Thoracic Society. 2015;12(11): 1602–1611.
- Denning DW, Pashley C, Hartl D, Wardlaw A, Godet C, Del Giacco S, et al. Fungal allergy in asthma-state of the art and research needs. Clinical and Translational Allergy. 2014;4: 14.
- Angrill J, Agusti C, de Celis R, Rañó A, Gonzalez J, Solé T, et al. Bacterial colonisation in patients with bronchiectasis: Microbiological pattern and risk factors. Thorax. 2002;57(1): 15–19.
- Maiz L, Nieto R, Canton R, Gómez G de la Pedrosa E, Martinez-García MÁ. Fungi in bronchiectasis: A concise review. International Journal of Molecular Sciences. 2018;19(1): pii:E142.
- Mares M, Moroti-Constantinescu VR, Denning DW. The burden of fungal diseases in Romania. Journal of Fungi (Basel). 2018;4(1): 31.
- Milla CE, Wielinski CL, Regelmann WE. Clinical significance of the recovery of Aspergillus species from the respiratory secretions of cystic fibrosis patients. Pediatric Pulmonology. 1996;21(1): 6–10.
- Moss RB. Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis. Seminars in Respiratory and Critical Care Medicine. 2015;36(2): 207–216.